Welcome to AMYPAD!
We were a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging. AMYPAD was funded from October 2016 until September 2022.
The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) initiative aimed to:
- improve the diagnostic work-up of people suspected to have Alzheimer’s disease and their management
- understand the natural history of the disease in a pre-symptomatic stage
- select people for treatment trials aiming at preventing Alzheimer’s disease
|
|
|
Neuraceq™ (left) and Vizamyl™ (right). Upper images: amyloid negative scans. Lower images: amyloid positive scans.
Latest News
New AMYPAD paper highlighting European collaboration with global impact is out
20 Jan 2023
In this new article, AMYPAD partners highlighted the important collaborations necessary to make a successful consortium......
New study assessing the psychological outcomes of the amyloid-PET result disclosure in people with SCD
17 Jan 2023
A total of 105 participants with SCD+ of AMYPAD DPMS, who received their amyloid-PET results, participated in this study......
Welcome to the 23rd issue of the AMYPAD Newsletter
02 Dec 2022
After 6 years of hard work of collecting data, the rewarding task to analyse and explore the wealth of ~3500 amyloid PET scans......
"We would hope that the direct results of the project are useful about our thinking of when amyloid deposition starts and when it's clinically relevant. But what is even more important is that the consortium that we formed, started collaborating on things that go well beyond the initial goals of AMYPAD. And actually, we should further integrate AMYPAD, EPAD and all the European cohorts that are now collaborating and joining forces in analysis of PET/MRI scans, imaging, biomarker but also genetic data. It is something of great value and will contribute to the future of all samples, definitely in Europe and hopefully also globally. ” Frederik Barkhof
AMYPAD Project Coordinator and Professor of Neuroradiology at VU University Medical Centre, Amsterdam and at University College London.
